Bharat Biotech International Limited (BBIL) has expanded its expertise from vaccine innovation to cutting-edge regenerative and personalized therapies that offer hope to millions of people by establishing India's only vertically integrated...
India's specialty chemicals industry is bouncing back in Q4 FY25, while pharma exports continue to grow at 8-9% backed by sustained demand for...
As society grows in knowledge and confidence regarding an available policy, training, and infrastructure, CAR-T cell therapy will shake up...
Eli Lilly and Company has launched Mounjaro in a single-dose vial, which has been authorized to be marketed by the Central Drugs Standard Control Organization (CDSCO). This first-ever treatment drug...
The central government has been urged to reconsider discussions about reducing import taxes on medical devices from the United States by the Association of Indian Medical Device Industry (AIMED). According to the industry organization, these changes
In a tactical initiative to improve drug safety oversight, Tech Mahindra, a worldwide frontrunner in technology consulting and digital services, has revealed an AI-based pharmacovigilance (PV) solution utilizing NVIDIA AI software. The solution seeks
Zydus Lifesciences Limited has established itself as a strong player in the world oncology market with its recent FDA approval to manufacture and sell a generic version of Apalutamide 60 mg tablets for the treatment of prostate cancer. The drug will
A major achievement for India's biotech industry and cancer treatment has occurred as the Delhi-based startup Cellogen Therapeutics has received...
The main SGLT2 inhibitor Xenia (empagliflozin and its combos) was introduced by USV, an Indian global healthcare business, to treat type 2 diabetes patients' heart failure, chronic renal disease, and glycaemic management.
LONDON, UK - March 19: The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making.